A novel frameshift mutation in PMP22 accounts for hereditary neuropathy with liability to pressure palsies

Neurology

Volumn 48, Issue 2, 1997, Pages 450-452

  Young, Peter ^a   Wiebusch, H ^a   Stogbauer F ^a   Ringelstein, B ^a   Assmann, G ^a   Funke, H ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN PROTEIN;

ADULT; AGED; ARTICLE; CHILD; CHROMOSOME 17P; CHROMOSOME DELETION; CLINICAL ARTICLE; FEMALE; FRAMESHIFT MUTATION; GENETIC DISORDER; HUMAN; MALE; MOTOR NERVE CONDUCTION; NERVE PARALYSIS; NEUROPATHY; PEDIGREE ANALYSIS; PRIORITY JOURNAL; PROTEIN DEFICIENCY;

EID: 0031028126     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.48.2.450     Document Type: Article

References (12)

1. Yoshikawa H, Nishimura T, Nakatsuji Y, et al. Elevated expression of messenger RNA for peripheral myelin protein 22 in biopsied peripheral nerves of patients with Charcot-Marie-Tooth disease type 1A. Ann Neurol 1994;35:445-450.
2. Lorenzetti D, Pareyson D, Sghirlanzoni A, et al. A 1.5-Mb deletion in 17p11.2-p12 is frequently observed in Italian families with hereditary neuropathy with liability to pressure palsies. Am J Hum Genet 1995;56:91-98.
3. Timmerman V, Nelis E, Van Hul W, et al. The peripheral myelin protein gene PMP-22 is contained within the Charcot-Marie-Tooth disease type 1A duplication. Nat Genet 1992;1: 171-175.
4. Lupski JR, Montes de Oca-Luna R, Slaugenhaupt S, et al. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 1991;66:219-232.
5. Roa BB, Garcia CA, Suter U, et al. Charcot-Marie-Tooth disease type 1A: association with a spontaneous point mutation in the PMP-22 gene. New Engl J Med 1993;329:96-101.
6. Nicholson GA, Valentijn LJ, Cherryson AK, et al. A frame shift mutation in the PMP22 gene in hereditary neuropathy with liability to pressure palsies [published erratum appears in Nat Genet 1994;7:113]. Nat Genet 1994;6:263-266.
7. Hultman T, Stahl S, Hornes E, Uhlen M. Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as a solid support. Nucleic Acids Res 1989;17:4937-4946.
8. Young P, Wiebusch H, Stoegbauer F, Ringelstein B, Assmann G, Funke H. Four frequently observed polymorphisms in the 3′-UTR of human peripheral myelin protein 22 (PMP22): identification of different haplotypes. Clin Genet 1996;49:321-322.
9. Patel PJ, Roa BB, Welcher AA, et al. The gene for the peripheral myelin protein PMP-22 is a candidate for Charcot-Marie-Tooth disease type 1A. Nat Genet 1992;1:159-165.
10. Roa BB, Dyck PJ, Marks HG, Chance PF, Lupski JR. Dejerine-Sottas syndrome associated with point mutation in the peripheral myelin protein 22 (PMP22) gene. Nat Genet 1993;5:269-273.
11. Adlkofer K, Martini R, Aguzzi A, Zielasek J, Toyka KV, Suter U. Hypermyelination and demyelinating peripheral neuropathy in PMP22-deficient mice. Nat Genet 1995;11:274-280.
12. Schenone A, Nobbio L, Mandich P, et al. Underexpression of messenger RNA for peripheral myelin protein 22 in hereditary neuropathy with liability to pressure palsies. Neurology 1997; 48:445-449.